Long-term tralokinumab therapy in moderate to severe atopic dermatitis

被引：0
|
作者：
Lorenz, Judith
机构：
来源：
AKTUELLE DERMATOLOGIE | 2023年 / 49卷 / 03期
关键词：
D O I：
10.1055/a-1974-5392
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：91 / 91
页数：1
相关论文
共 50 条
  • [1] LONG-TERM EFFICACY OF TRALOKINUMAB IN ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Wollenberg, Andreas
    Paller, Amy S.
    Bewley, Anthony
    Cork, Michael
    Hong, Chih-Ho
    Soong, Weily
    Oland, Christian Bjerregard
    Taveira, Christian Moreira
    Gjerum, Le
    Blauvelt, Andrew
    [J]. ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 54 - 54
  • [2] Stability of long-term therapeutic responses to tralokinumab in adults with moderate-to-severe atopic dermatitis
    Blauvelt, Andrew
    Hong, H. Chih-ho
    Peris, Ketty
    Katoh, Norito
    Tauber, Marie
    Ameen, Mahreen
    Gooderham, Melinda
    Oland, Christian Bjerregard
    Tindberg, Ann-Marie
    Gjerum, Le
    Reich, Kristian
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 30 - 31
  • [3] Long-Term Improvement in Patients with moderate to severe atopic Dermatitis treated with Tralokinumab: An ECZTEND Interim Analysis
    Beissert, Stefan
    Blauvelt, Andrew
    Lacour, Jean-Philippe
    Toth, Darryl
    Laquer, Vivian
    Herranz, Pedro
    Pink, Andrew
    Peris, Ketty
    Fangel, Stine
    Saeki, Hidehisa
    Wollenberg, Andreas
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 29 - 30
  • [4] Long-term safety and efficacy of tralokinumab in adolescents with moderate-to-severe atopic dermatitis: an interim analysis of ECZTEND
    Simpson, Eric
    Paller, Amy
    Wollenberg, Andreas
    Bewley, Anthony
    Cork, Michael
    Hong, Chih-Ho
    Soong, Weily
    Almgren, Peter
    Carlsson, Anna
    Blauvelt, Andrew
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB190 - AB190
  • [5] Long-term Efficacy of Intravenous Immunoglobulin Therapy for Moderate to Severe Atopic Dermatitis in Childhood
    Oh, J.
    Kim, J.
    Baik, H.
    Lee, H.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB36 - AB36
  • [6] Long-term Efficacy of Intravenous Immunoglobulin Therapy for Moderate to Severe Childhood Atopic Dermatitis
    Jee, Sue-Jung
    Kim, Joo-Hwa
    Baek, Hey-Sung
    Lee, Ha-Baik
    Oh, Jae-Won
    [J]. ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2011, 3 (02) : 89 - 95
  • [7] Long-term improvements observed in tralokinumab-treated patients with moderate-to-severe atopic dermatitis: an ECZTEND interim analysis
    Blauvelt, A.
    Lacour, J. -P.
    Toth, D.
    Laquer, V.
    Beissert, S.
    Wollenberg, A.
    Herranz, P.
    Pink, A.
    Peris, K.
    Fangel, S.
    Saeki, H.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E112 - E113
  • [8] Continuous tralokinumab treatment over 4 years in adults with moderate-to-severe atopic dermatitis provides long-term disease control
    Blauvelt, Andrew
    Langley, Richard G.
    Peris, Ketty
    Silvestre, Juan Francisco
    Katoh, Norito
    Tauber, Marie
    Pinter, Andreas
    Ameen, Mahreen
    Gooderham, Melinda
    Oland, Christian Bjerregard
    Tindberg, Ann-Marie
    Gjerum, Le
    Reich, Kristian
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II48 - II49
  • [9] Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis
    Edwards, Steven J.
    Karner, Charlotta
    Jhita, Tracey
    Barton, Samantha
    Marceniuk, Gemma
    Yiu, Zenas Z. N.
    Wittmann, Miriam
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2024, 28 (04)
  • [10] Efficacy and safety of long-term treatment with dupilumab for moderate to severe atopic dermatitis
    Ikeda, M.
    Uehara, H.
    Tsuge, M.
    [J]. ALLERGY, 2019, 74 : 182 - 182
12345